| Literature DB >> 35117674 |
Mir Faeq Ali Quadri1, Abdul Wahab H Alamir2, Tenny John2, Maryam Nayeem3, Abbas Jessani4, Santosh Kumar Tadakamadla5.
Abstract
BACKGROUND: To review the evidence on the oral health-related quality of life (OHRQoL) of head and neck cancer survivors after they have been treated with prosthetic rehabilitation.Entities:
Keywords: Head and neck cancer; oral cancer; oral functions; oral health-related quality of life (OHRQoL); prosthetic rehabilitation; systematic review
Year: 2020 PMID: 35117674 PMCID: PMC8797697 DOI: 10.21037/tcr.2019.12.48
Source DB: PubMed Journal: Transl Cancer Res ISSN: 2218-676X Impact factor: 1.241
Search terms and search strategy used in retrieving the articles
| Search steps | Search terminologies |
|---|---|
| #1 | Oral OR Dental OR Mouth OR intra oral OR gingiva OR Palate or Palatal OR oropharynx OR Cheek OR Head AND Neck |
| #2 | Cancer* OR neoplas* OR carcinoma* OR tumour* OR tumor OR malignan* |
| #3 | #1 AND #2 |
| #4 | Head and Neck Neoplasms OR Squamous Cell Carcinoma of Head and Neck OR Mouth Neoplasms OR Gingival Neoplasms OR Lip Neoplasms OR Palatal neoplasms OR Salivary gland neoplasms OR Tongue neoplasms |
| #5 | #3 OR #4 |
| #6 | Quality of life [tiab] OR Wellbeing [tiab] OR Well-being [tiab] OR Health related Quality of life [tiab] OR HRQOL [tiab] OR Life quality [tiab] OR Daily performances [tiab] OR Daily activities [tiab] OR Daily living [tiab] OR Patient Reported Outcome Measures [tiab] OR Health outcomes [tiab] OR Patient outcome [tiab] |
| #7 | #3 AND #6 |
Search steps were used in appropriate combinations to retrieve the articles. *, truncation was used to broaden the search.
Figure 1PRISMA flow-chart illustrating the study selection process. PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses.
General characteristics of the included studies
| Author/year | Place of study | Objective of the study | Study type | Mean age (SD) | Sample size (N) |
|---|---|---|---|---|---|
| Sato | Japan | Evaluate the changes in OHRQoL and self-assessed masticatory ability and investigate the relationship between the self-assessed masticatory ability and occlusal force in patients that underwent oral tumor resection and mandibular implant-supported prosthesis (ISP) placement | Experimental study | Not mentioned | N=10: male =6, female =4 |
| Fromm | Denmark | To evaluate the OHRQoL as well as the esthetic and functional outcome of oral rehabilitation in HNC—patients compared to non-HNC patients | Prospective experimental study | 70.2 (10.6). Age and gender are matched | N=18: male =12, female =6 |
| Akinmoladun | Nigeria | To appraise the pattern and challenges of managing patients with maxillectomy and the QoL of a subset of the study population | Cross sectional study | 35.88 (14.9) | N=67: male =30, female =37 |
| Hagio | Japan | To identify factors affecting the improvement of OHRQoL by using maxillofacial prosthetic treatment after surgery to repair maxillary, mandibular, tongue, and oral floor defects | Prospective experimental study | 72.4 (8.7) | N=50: male =34; female =16 |
| Dholam | India | Primary—to assess the impact of dental rehabilitation on patients’ OHRQoL following treatment for cancer of oral cavity using LORQv3 and OHIP-14 questionnaire | Experimental study | 51 | N=75: male =50, female =25 |
| Schweyen | Germany | To evaluate OHRQoL in long-term survivors after RT for HNC and to compare the results with a normal population | Prospective experimental study | 57.7 | N=116: males =87, females =29 |
| Fierz | Switzerland | To document tumor patients’ QoL 3 to 6 years after prosthetic rehabilitation. | Cross-sectional study | Not mentioned | N=18: male =13, female =5 |
| Linsen | Germany | To investigate the prevalence of TMD in patients with oral cancer after surgery and prosthodontic rehabilitation, and to evaluate the correlation between TMD, the maximum voluntary bite force, OHRQoL | Experimental study | 62 [16] | N=26: male =14 |
OHRQoL, oral health-related quality of life; SD, standard deviation; HNC, head and neck cancer; RT, radiotherapy; TMD, temporomandibular disorders.
Description of head and neck cancers, and the treatment provided
| Author/year | Site | Type of OC | T/t performed, type of surgery [chemotherapy, radiotherapy (RT)] | Implant supported | Follow-up period |
|---|---|---|---|---|---|
| Sato | Mandible =10 | Squamous cell carcinoma =5, benign =5 | Tumor resection =10, + chemotherapy =1, chemotherapy + RT =1 | Yes [10] | 1 year |
| Fromm | Maxilla =5, mandible =1, base of mouth =5, hypopharynx =2, sino-nasal =1, salivary =1, cutaneous =1, oropharynx =2 | Cancer cavum oris =11, other cancer types =7 | Total RT =12, only RT =0, RT + surgery =4, RT + chemotherapy =2, RT + surgery + chemotherapy =6, non-RT =6, surgery alone =6 | Not mentioned | 1 year |
| Akinmoladun | Maxilla =32 | Chondrosarcoma =1, hemangiopericytoma =1, osteogenic sarcoma =4, squamous cell carcinoma =7, ameloblastic fibrosarcoma =1, malignant ameloblastoma =1, adenocarcinoma =2, adenoid cystic carcinoma =10, mucoepidermoid carcinoma =3, polymorphous low-grade adenocarcinoma =2 | Surgery and prosthetic reconstruction for all | Not mentioned | 2 years |
| Hagio | Hard palate =24, soft palate =1, mandible =17, tongue =5, oral floor =3 | Not mentioned | Surgery and prosthetic reconstruction for all. None of the defects in maxilla underwent reconstructive surgery | Not mentioned | 1 year |
| Dholam | Palate (34%), upper alveolus (19%), buccal mucosa (15%), tongue (13%), gingivobuccal sulcus (7%), lower alveolus (7%), and retromolar trigone (5%) | Squamous cell carcinoma (73%), mucoepidermoid carcinoma (5%), adenoid cystic carcinoma (12%), ameloblastoma (1%), others (8%) | Surgery + chemotherapy + RT, partial dentures =20, complete dentures =10 | Not mentioned | 1 year |
| Schweyen | Nasopharynx =6, oropharynx =31, uvula =1, tongue base =6, oral cavity =38, parotid gland =9, hypopharynx/larynx =25 | Not mentioned | No dentures or FPD =44, CD =30, RPD =42 | Yes for 4 patients | 1 year |
| Fierz | Maxilla =5+3*, Mandible =10+3* (*, 3 patients had tumor in both jaws) | Squamous cell carcinoma =14, other tumors =4 | Obturator prothesis =3, bar prosthesis on implant (with obturator in maxilla) =8, fixed prosthesis on implant =5, partial prothesis (tooth-supported) =2, wire-clip provisional prosthesis =2, only vacuum-drawn splint (for fluoridation) =1 | Yes | 2 years and 3 months |
| Linsen | Maxilla =14, mandible =12 | Squamous cell carcinoma =18, adenoid cystic carcinoma =3, Keratocyst =2, enameloblastoma =2, osteosarcoma =1 | Partial resection with segmental mandibulectomy =8, bony reconstruction =6, without bony reconstruction =2 | Yes | Not mentioned |
OC, oral cancer; T/t, treatment; FPD, fixed partial denture; CD, complete denture; RPD, removable partial denture.
OHRQoL of head and neck cancer (HNC)survivors with prosthetic rehabilitation
| Author/year | Name of OHRQoL questionnaire | Oral functions assessed | Analyses used | Results | Conclusion |
|---|---|---|---|---|---|
| Sato | Japanese version of the Oral Health Impact Profile (OHIP-49) | Masticatory ability. Occlusal force | Wilcoxon signed-rank test | OHIP-49: before =65.3±9.79, after =46.0±8.14 | Implant placement improves OHRQoL and the self-assessed masticatory ability |
| Masticatory ability: before =54.5±9.79, after =68.0±8.37 | The prosthesis types might not significantly affect OHRQoL | ||||
| Fromm | Danish version OHIP-49 | The Nordic Orofacial Test-Screening (NOT-S) 24 | Independent | Mean OHIP-49: case =42.50 | Oral function is significantly impaired in HNC-patients compared to non-HNC-patients after oral rehabilitation |
| Mean NOT-S: case =4.56 | The mean OHIP-49 score was more among cases in comparison to controls | ||||
| Akinmoladun | UW-QoL | Swallowing, chewing, speech, taste and saliva | Mean (SD) and % | UW-QoL scores: swallowing =97.2 (2.8), chewing =78.1 (3.1), speech =83.3 (4.2), taste =81.3 (4.1), saliva =100 (0) | Oral functions of the patients after treatment were not fully restored |
| Red | |||||
| Hagio | Oral Health Impact Profile (OHIP-J54) | Masticatory function, swallowing function, and articulatory function | Wilcoxon signed-rank test | Results from mandibular reconstruction (pre | OHRQoL of participants was improved in cancer survivors of the maxillary defect group |
| Green | |||||
| Dholam | OHIP-14 | Chewing, swallowing, salivation, speech, mouth opening, oro-facial appearance, social interaction | Two group comparisons were made using Mann-Whitney U-test. Three or more group comparisons were made using Kruskal-Wallis test | PD, mean (SD): Chewing 1.45 (0.38), Swallowing 1.12 (0.32), Salivation 1.43 (0.46), Speech 1.15 (0.37), Mouth opening 1.10 (0.31), Orofacial appearance 1.27 (0.44) | The oral cancer patients coped well and adapted to near normal oral status after prosthetic rehabilitation |
| CD, mean (SD): Chewing 2.0 (0.83), Swallowing 1.40 (0.57), Salivation 1.42 (0.43), Speech 1.20 (0.42), Mouth opening 1.0 (0), Orofacial appearance 1.30 (0.48) | This showed improved QoL after one year of dental rehabilitation | ||||
| Schweyen | OHIP -14 | Not specified | Mann-Whitney U test, Kruskal-Wallis test, linear regression | Denture status [N, mean OHIP (SD)]: none [44, 16.7 (15.5)], RPD [42, 21.2 (16.4)], FPD [30, 20.1 (16.7)] | Prosthetic treatment in HNC patients do not lead to the same improvement in OHRQoL as found in the normal population |
| Fierz | EORTC QLQ | Sticky saliva, xerostomia, mouth opening, problems with teeth, chewing swallowing, tmj pain, oral pain | Mean (SD) and % | At least “a little effect” reported; sticky saliva =60–70%, xerostomia =40–60%, mouth opening =45–62%, problems with teeth =70–82%, chewing-Swallowing =68–72%, TMJ pain =65–89%, oral pain =45–77% | Most of the surveyed patients responded rather positively to questions about their post-treatment quality of life |
| Linsen | OHIP-G | Sensitive teeth, toothache, painful gum | Fisher’s exact test, two-sided Cochran-Armitage trend test | Sensitive teeth, P=0.01; toothache, P=0.02; painful gum, P=0.03 | The OHRQoL of patients with oral cancer shows a satisfactory outcome |
OHRQoL, oral health-related quality of life; UW-QoL, University of Washington quality of life; SD, standard deviation; EORTC QLQ, European Organization for Research and Treatment of Cancer’s Quality of Life Questionnaire; CD, complete denture; PD, partial denture.
Quality analyses report of the included studies
| Assessment criteria | Quality scores | |||||||
|---|---|---|---|---|---|---|---|---|
| Sato | Fromm | Akinmoladun | Hagio | Dholam | Schweyen | Fierz | Linsen | |
| 1. A clearly stated aim | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 2 |
| 2. Inclusion of consecutive patients | 2 | 1 | 2 | 2 | 1 | 2 | 1 | 1 |
| 3. Prospective collection of data | 2 | 0 | 0 | 2 | 2 | 2 | 0 | 2 |
| 4. Endpoints appropriate to the aim of the study | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| 5. Unbiased assessment of the study endpoint | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| 6. Follow-up period appropriate to the aim of the study | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 |
| 7. Loss to follow-up less than 5% | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| 8 Prospective calculation of the study size | 0 | 2 | 0 | 2 | 0 | 2 | 0 | 0 |
| 9. An adequate control group | 0 | 2 | 0 | 0 | 1 | 0 | 0 | 0 |
| 10. Contemporary groups | 0 | 2 | 0 | 0 | 1 | 0 | 0 | 0 |
| 11. Baseline equivalence of groups | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| 12. Adequate statistical analyses | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 11 | 15 | 9 | 13 | 13 | 13 | 9 | 10 |
†, the items are scored 0 (not reported), 1 (reported but inadequate) or 2 (reported and adequate). Global ideal score being 16 for non-comparative studies and 24 for comparative studies.